Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ekman, Ulrika T
NCT04167306 / 2018-000048-24: Varenicline and Bupropion for Alcohol Use Disorder	Completed	2	388	Europe	Varenicline Tartrate 1 mg b.i.d, Champix, Bupropion Hydrochloride 150 mg b.i.d, Bupropion Sandoz, Placebo for varenicline, Placebo for bupropion	Vastra Gotaland Region	Alcohol Use Disorder, Alcoholism, Alcohol Dependence	12/22	12/22

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ekman, Ulrika T
NCT04167306 / 2018-000048-24: Varenicline and Bupropion for Alcohol Use Disorder	Completed	2	388	Europe	Varenicline Tartrate 1 mg b.i.d, Champix, Bupropion Hydrochloride 150 mg b.i.d, Bupropion Sandoz, Placebo for varenicline, Placebo for bupropion	Vastra Gotaland Region	Alcohol Use Disorder, Alcoholism, Alcohol Dependence	12/22	12/22